This is a cancer-fighting biotech that’s up nearly 200 percent over the past year, could it be a winner again in 2015? » Subscribe to CNBC: …
source CNBC
TG Therapeutics CEO: Cancer-Fighting Biotech | Mad Money | CNBC
This is a cancer-fighting biotech that’s up nearly 200 percent over the past year, could it be a winner again in 2015? » Subscribe to CNBC: …
source CNBC
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More